Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
BIOX · Nasdaq · United States · Agricultural Chemicals
In shortBioceres Crop Solutions Corp. is loss-making, generates cash and carries moderate debt, with revenue shrinking (−27.9% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -0.7% | 14/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -16.5% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -19.1% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -0.4% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 0.91× | 9/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.59× | 78/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -0.08× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 13.2% | 73/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 31.5% | 0/100 |
| Operating margin volatility | 7.0% | 46/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 0.0% | 17/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 210 | 335 | 420 | 465 | 335 |
| Cost of revenue | 119 | 208 | 235 | 278 | 203 |
| Gross profit | 91 | 126 | 185 | 187 | 132 |
| Research & development | 5.6 | 6.9 | 15 | 17 | 15 |
| Selling, general & admin | 48 | 77 | 113 | 124 | 123 |
| Operating income | 38 | 40 | 54 | 46 | (2.2) |
| Interest expense | 21 | 18 | 24 | 27 | 29 |
| Pre-tax income | 11 | 14 | 19 | 11 | (58) |
| Income tax | 14 | 18 | (1.1) | 3.8 | 1.3 |
| Net income | (6.9) | (7.2) | 19 | 4.3 | (55) |
| Diluted EPS | −$0.18 | −$0.17 | $0.30 | $0.07 | −$0.88 |
| Diluted shares (millions) | 39 | 42 | 63 | 63 | 63 |
4 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of Bioceres Crop Solutions Corp. are included in the Investor plan. Try free for 7 days →
Not computed: a required balance-sheet item is missing.
3/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice.
Latest annual report: Jun 30, 2025 · Data updated Mar 13, 2026